Legal Representation
Attorney
Cheryl L. Foytlin
USPTO Deadlines
Next Deadline
123 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
November 21, 2025
Extension Available
Until November 21, 2024
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 2, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 1, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 1, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 1, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 25, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 25, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 16, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 15, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 15, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 15, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 24, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 24, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 12, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Classification
International Classes
005